ClinicalTrials.gg
CompletedNCT06504498Updated Jul 16, 2024

Effectiveness of Clear Aligners in Different Thicknesses

An interventional study of 0.5 mm-thick Duran® clear aligner and 0.75 mm-thick Duran® clear aligner in Angle's Class I Malocclusion and Crowding, Tooth, sponsored by Mersin University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-16.

Sponsored by Mersin University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 1 month after the study started (first participant enrolled May 2021, registered Jun 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aimed to evaluate the effectiveness, pain, and satisfaction levels between patients treated with different thicknesses of clear aligners among Class I maxillary mild crowding cases. Two types of clear aligners with thicknesses of 0.5 and 0.75 mm were used. The null hypotheses were as follows: There is no clinical difference in effectiveness, pain, and satisfaction levels between different thickness of clear aligners. The alternate hypotheses were as follows: The thicker the clear aligner, the greater orthodontic force applied to tooth which affects the amount of orthodontic tooth movement, pain, and satisfaction levels of patients. The primary aim was to evaluate pre- and post-treatment changes in amount of orthodontic tooth movement. Maxillary cephalometric parameters were measured on lateral cephalograms and maxillary dental parameters were measured using OrthoAnalyzer, and compared before and after treatment. Visual Analogue Scale and Patient Satisfaction Evaluation Form were used in order to assess the pain and satisfaction levels of patients. Pain and satisfaction levels were measured before the aligner insertion (T0), at the 4th hour (T1), 2nd day (T2), 1st week (T3), 1st month (T4) and at the end of the treatment (T5).

Read the detailed description

The sample size was computed to detect difference in the amount of orthodontic tooth movement between groups (G*Power, University of Dusseldorf, Germany). The calculated sample size was 14 for each group, similar to the previously published study (effect size = 0.8, α = 0.05, and 1 - β = 0.80). Lateral cephalograms were taken for all patients using the X-ray device (PM 2002 EC Proline; Planmeca OY, Helsinki, Finland) in the Department of Oral and Maxillofacial Radiology. Patients who satisfied the inclusion criteria were enrolled in this study and they were randomly separated into 2 groups (Group 1 and Group 2) based on the aligner thickness, each consisted of 14 patients. Patients in Group 1 were treated with 0.5 mm-thick clear aligners, patients in Group 2 were treated with 0.75 mm-thick clear aligners. The Little's Irregularity Index were calculated using OrthoAnalyzer software (3Shape, Copenhagen, Denmark) to standardize the amount of maxillary anterior crowding at the beginning of the treatment. Initial records were taken at the beginning of the treatment using an intraoral scanner (Trios 3®, 3Shape, Copenhagen, Denmark). Scanned data has been converted to standard tessellation language (STL) files and these files have been modified to create virtual setups for orthodontic tooth movement using OrthoAnalyzer software. Virtual setups were imported into a slicing software for model preparation before printing. A stereolithographic (SLA) 3D printer and liquid photopolymer were used to print resin models. These models were used as mould for thermoforming of the aligners using a vacuum-thermoforming machine (Model No: 202, Keystone Industries, Myerstown, USA). All aligners were manually cut with straight trim lines at gingival zenith to provide better comfort for the patients. Attachments were placed according to the software and interproximal reductions were performed by the same operator (SMC). Patients were followed at 2nd day (T2), 1st week (T3), 1st month (T4) and at the end of the treatment (T5). Pre- (T0) and post-treatment (T5) digital models, lateral cephalometric radiographs were compared. Pain and satisfaction levels of patients were assessed using Visual Analogue Scale and Patient Satisfaction Evaluation Form.

02

Conditions studied

  • Angle's Class I Malocclusion
  • Crowding, Tooth

Keywords

  • Clear aligner thickness
  • Orthodontic tooth movement
  • Pain
03

In context

Malocclusion, Angle Class I

35 studies on the registry are indexed under Malocclusion, Angle Class I; 10 are open to participants now.

This study's enrollment of 28 is below the median of 32 across 31 interventional studies indexed under Malocclusion, Angle Class I.

Browse Malocclusion, Angle Class I studies →

Lead sponsor

Mersin University is the lead sponsor of 176 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Angle Class I malocclusion without skeletal discrepancy,
  2. Patients older than 18 years old with a full permanent dentition without supernumerary missing or impacted teeth except for 3rd molars,
  3. Non-extraction cases with mild crowding in maxillary arch (2-5 mm),
  4. Good oral health without periodontal disease or caries,
  5. No previous orthodontic treatment,
  6. Not taking pain medications.

Exclusion criteria

Exclusion Criteria:

  1. History of previous orthodontic or interceptive treatment,
  2. Extraction cases with crowding of > 5 mm,
  3. Presence of anterior or posterior openbite or crossbite,
  4. Unwilling to be treated with clear aligners,
  5. Presence of supernumerary, missing or impacted teeth (other than third molars),
  6. Presence of any local/systemic problems or trauma, which may affect the pain level.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Active comparator
    0.5 mm-thick Duran® clear aligners

    0.5 mm-thick clear aligners (Duran®; Scheu-Dental GmBH, Iserlohn, Germany).

    Device: 0.5 mm-thick Duran® clear aligner

  • Experimental
    0.75 mm-thick Duran® clear aligners

    0.75 mm-thick clear aligners (Duran®; Scheu-Dental GmBH, Iserlohn, Germany).

    Device: 0.75 mm-thick Duran® clear aligner

Interventions

  • Device0.5 mm-thick Duran® clear aligner

    0.5 mm-thick clear aligner was used for orthodontic treatment.

  • Device0.75 mm-thick Duran® clear aligner

    0.75 mm-thick clear aligner was used for orthodontic treatment.

06

What researchers measure

Primary outcomes

  1. Radiographic tooth movement

    Changes in the amount of maxillary cephalometric parameters using lateral cephalometric radiographs after 6 months.

    Time frame: At 6th months

  2. Orthodontic tooth movement

    Changes in intercanine, interpremolar, intermolar arch expansions and dental arch perimeter (maxillary dental parameters) using OrthoAnalyzer® software after 6 months.

    Time frame: At 6th months

Secondary outcomes

  1. Patients' pain level

    Changes in patients' pain level using a 10-cm VAS using ''no pain'' and ''severe pain'' as anchor descriptions at the 4th hours, 2nd days, 1st week, 1st month, and 6th months.

    Time frame: At the 4th hours, 2nd days, 1st week, 1st month, and 6th months

  2. Patients' satisfaction level

    Changes in patients' satisfaction level using ''Patient Satisfaction Evaluation Form 1'' at the 4th hours, 2nd days, 1st week, 1st month; and using ''Patient Satisfaction Evaluation Form 2'' at the 6th months.

    Time frame: At the 4th hours, 2nd days, 1st week, 1st month, and 6th months

07

Study locations

1 site
  • Mersin University Faculty of Dentistry Department of Orthodontics
    Mersin, 33110, Turkey (Türkiye)
08

References and documents

Publications

  • Sachdev S, Tantidhnazet S, Saengfai NN. Accuracy of Tooth Movement with In-House Clear Aligners. J World Fed Orthod. 2021 Dec;10(4):177-182. doi: 10.1016/j.ejwf.2021.08.003. Epub 2021 Oct 5. PubMed 34625386 ↗
  • Ho CT, Huang YT, Chao CW, Huang TH, Kao CT. Effects of different aligner materials and attachments on orthodontic behavior. J Dent Sci. 2021 Jul;16(3):1001-1009. doi: 10.1016/j.jds.2021.01.011. Epub 2021 Feb 12. PubMed 34141116 ↗
  • Cengiz SM, Goymen M. The effectiveness of orthodontic treatment with clear aligners in different thicknesses. Sci Rep. 2025 Feb 1;15(1):3958. doi: 10.1038/s41598-025-86345-9. PubMed 39893227 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2021 to primary completion in Jan 2022, 8 months.

Of 23 interventional studies with no phase under Malocclusion, Angle Class I, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 24. This study's 8 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2024
First posted
Jul 16, 2024
StartActual
May 10, 2021
Primary completionActual
Jan 21, 2022
CompletionActual
May 20, 2022
Last update
Jul 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06504498
Lead sponsor
Mersin University
Responsible party
Saniye Merve CENGIZ (Assistant Professor, Mersin University) — Principal investigator
First posted
Jul 16, 2024
Start date
May 10, 2021
Primary completion
Jan 21, 2022
Completion
May 20, 2022
Last update
Jul 16, 2024

Study contacts

Merve Göymen, Assoc Prof
study director · Study Director

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion